QQ客服 官方微博 反馈留言

浏览/检索结果: 共3条，第1-3条 帮助 限定条件 发表日期：2019     已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 Metronomic capecitabine combined with aromatase inhibitors for new chemoendocrine treatment of advanced breast cancer: a phase II clinical trial 期刊论文 BREAST CANCER RESEARCH AND TREATMENT, 2019, 卷号: 173, 期号: 2 作者:  Lei, Li;  Li, Jian-wei;  Zuo, Wen-jia;  Ivanova, Diana;  Jia, Xiao-qing 收藏  |  浏览/下载：13/0  |  提交时间：2019/12/04 Advanced breast cancer  Hormone receptors positive breast cancer  Metronomic chemoendocrine therapy  Aromatase inhibitors  Capecitabine  Endocrine resistance   Metronomic capecitabine combined with aromatase inhibitors for new chemoendocrine treatment of advanced breast cancer: a phase II clinical trial 期刊论文 BREAST CANCER RESEARCH AND TREATMENT, 2019, 卷号: 173, 期号: 2 作者:  Li, Jian-wei;  Zuo, Wen-jia;  Ivanova, Diana;  Jia, Xiao-qing;  Lei, Li 收藏  |  浏览/下载：22/0  |  提交时间：2019/12/05 Advanced breast cancer  Hormone receptors positive breast cancer  Metronomic chemoendocrine therapy  Aromatase inhibitors  Capecitabine  Endocrine resistance   Young Patients with Hormone Receptor-Positive Breast Cancer Have a Higher Long-Term Risk of Breast Cancer Specific Death 期刊论文 JOURNAL OF BREAST CANCER, 2019, 卷号: 22, 页码: 96-108 作者:  Fu, Jianfei;  Zhong, Chenhan;  Wu, Lunpo;  Lie, Dan;  Xu, Tiantian 收藏  |  浏览/下载：21/0  |  提交时间：2019/11/19 Breast neoplasms  Estrogen receptors  Drug therapy  Prognosis